172 results
DEFA14A
CHRS
Coherus Biosciences Inc
15 Apr 24
Additional proxy soliciting materials
5:10pm
) Kimberly J. Tzoumakas 2. To ratify the selection, by the Audit Committee of our Board of Directors, of Ernst & Young LLP as our independent registered
S-8
EX-23.2
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
Exhibit 23.2
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement
S-8
CHRS
Coherus Biosciences Inc
28 Mar 24
Registration of securities for employees
4:04pm
(included in Exhibit 5.1).
Consent of Independent Registered Public Accounting Firm.
Power of Attorney (included in the signature page
8-K
EX-2.1
26el2beum 9ftdo
22 Jan 24
Coherus Announces Agreement to Divest Ophthalmology Franchise to Sandoz in Conference Call Information
8:01am
8-K
lh4x7
9 Jan 24
Results of Operations and Financial Condition
9:41pm
8-K/A
EX-99.1
znitra y9
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K/A
EX-23.1
2mcp341j9pa
6 Nov 23
Report of Independent Registered Public Accounting Firm
6:07am
8-K
EX-99.1
02n15s739e2qs
27 Oct 23
Regulation FD Disclosure
4:19pm
424B5
zpu6 xv2iu3zszxsxim
12 Sep 23
Prospectus supplement for primary offering
6:04am